Open company graph database — free web & API
Login

Merck & Co., Inc.

メルク株式会社Alias
Ticker
—
Listed market
—
Country
United States of America
Employees (non-consolidated)
—
Related companies
2
§01

Basic information

BASIC
Head office
Not specified
Chief executive
Not specified
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

5
researchdevelopmedicinesvaccinesother products
§04

Related companies

2 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
citycancerchallenge.org
Alliance
Scherling Plough Corporation
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

9 EVENTS

Total Worldwide Sales Were $16.3 Billion (5% Growth; 3% Growth ex-FX)Sources

Sales Were $8.0 Billion (12% Growth; 8% Growth ex-FX); Includes KEYTRUDA QLEX Sales of $128 MillionSources

WINREVAIR Sales Were $525 Million (88% Growth; 87% Growth ex-FX)Sources

Animal Health Sales Were $1.8 Billion (13% Growth; 6% Growth ex-FX)Sources

GAAP Loss per Share Was $1.72; Non-GAAP Loss per Share Was $1.28; GAAP and Non-GAAP Loss per Share Include a Charge of $3.62 per Share for the Acquisition of CidaraSources

Presented New Data From Cardio-Pulmonary Pipeline at ACC.26, Including Positive Results From Phase 3 CORALreef AddOn TrialSources

Received U.S. FDA Approval for IDVYNSO, a Once-Daily, Oral Treatment for Certain Adults With Virologically Suppressed HIV-1Sources

Achieved Multiple Significant Regulatory and Clinical Milestones Across Oncology PipelineSources

Announced Agreement To Acquire Terns Pharmaceuticals, Inc. and Expand Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia; Transaction Expected To Close in MaySources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑